Titleist Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Buy
903
+26
+3% +$26.6K 0.07% 181
2026
Q1
$806K Buy
877
+91
+12% +$92.3K 0.06% 201
2025
Q4
$845K Buy
786
+52
+7% +$49.7K 0.07% 166
2025
Q3
$560K Sell
734
-55
-7% -$40.9K 0.05% 195
2025
Q2
$615K Buy
789
+258
+49% +$200K 0.06% 184
2025
Q1
$438K Buy
531
+20
+4% +$16.6K 0.05% 201
2024
Q4
$394K Buy
511
+44
+9% +$36.4K 0.05% 217
2024
Q3
$414K Hold
467
0.06% 192
2024
Q2
$423K Buy
467
+89
+24% +$71.2K 0.06% 182
2024
Q1
$294K Buy
+378
New +$269K 0.05% 209

Other funds holding LLY

Titleist Asset Management's LLY Position: Q2 2026 in Review

Titleist Asset Management increased its Eli Lilly (LLY) stake by 3% in Q2 2026, buying an estimated $26.6K and bringing the position to 903 shares worth $1.08M. The position accounts for 0.07% of the portfolio, ranked #181.

Titleist Asset Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Titleist Asset Management held 903 shares of Eli Lilly worth $1.08M as of Q2 2026.
  • Titleist Asset Management bought 26 Eli Lilly shares in Q2 2026, an estimated $26.6K.
  • Eli Lilly made up 0.07% of Titleist Asset Management's portfolio in Q2 2026, its #181 holding.
  • Titleist Asset Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Titleist Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.